All In Biotech

Drug Trial Radar · NCT00094497

Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)

First International Randomized Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment

Last checked: Nov 20, 2026Latest source record: Sep 21, 2016 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 304 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

304

Actual

Start

Jun 2004

Primary completion

Dec 2010

Study completion Dec 2010

Sponsor

Lead sponsor
Collaborative Group for Adrenocortical Carcinoma TreatmentAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
German Federal Ministry of Education and Research; National Cancer Institute (NCI)
First posted
Oct 20, 2004

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine whether treatment with etoposide, doxorubicin, cisplatin and mitotane (EDP/M) prolongs survival as compared to streptozotocin and mitotane (Sz/M) in patients with advanced adrenocortical carcinoma (ACC) whose disease is not amenable to complete surgical resection.

Conditions

  • Carcinoma, Adrenal Cortical

Interventions

  • EtoposideDrug

  • DoxorubicinDrug

  • CisplatinDrug

  • StreptozotocinDrug

  • MitotaneDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall SurvivalTime frame: every 8 weeks until death up to 5 years

Locations

32 sites in 8 countries. Site status is shown where the registry gives one.

  • National Cancer Institute - Center for Cancer Research

    Bethesda, Maryland

  • University of Michigan, Department of Internal Medicine

    Ann Arbor, Michigan

  • Royal Adelaide Hospital

    Adelaide, Australia

  • University of Graz

    Graz, Austria

  • Clinique Marc Linquette

    Lille, France

  • Centre Leon Berard

    Lyon, France

  • Hospital de Marseille la timone

    Marseille, France

  • Cochin Hospital

    Paris, France

  • Hospital Bordeaux haut leveque

    Pessac, France

  • Institut Gustave Roussy

    Villejuif, France

  • Charité-University, Dept. of Endocrinology; Campus Benjamin Franklin

    Berlin, Germany

  • Charité-Universitätsmedizin Berlin - Campus Mitte

    Berlin, Germany

  • Dept. of Medicine III

    Dresden, Germany

  • University of Duesseldorf, Dept. of Endocrrinology

    Düsseldorf, Germany

  • Zentrum für Innere Medizin - Endokrinologie des Universitätsklinikum Essen

    Essen, Germany

  • Endokrinologie Medizinische Hochschule Hannover

    Hanover, Germany

  • Otto-von-Guericke University; Dept. of Endocrinology

    Magdeburg, Germany

  • Dept of Medicine I

    Mainz, Germany

  • University of Munich, Dept. of Internal Medicine (Innenstadt)

    Munich, Germany

  • University of Wuerzburg - Dept. of Medicine

    Würzburg, Germany

  • University of Turin, Dept of Internal Medicine

    Orbassano, Italy

  • Clinica Endocrinologica, Università di Padova, Azienda Ospedaliera di Padova

    Padova, Italy

  • Vrije Universiteit Medisch Centrum

    Amsterdam, Netherlands

  • Academisch Medisch Centrum; Dept. of Endocrinology

    Amsterdam, Netherlands

  • Maxima Medisch Centrum; Dept. of Internal Medicine

    Eindhoven, Netherlands

  • University Hospital Groningen; Dept. of Internal Medine

    Groningen, Netherlands

  • Leiden University Medical Center

    Leiden, Netherlands

  • Department of Oncology, Sahlgrenska University Hospital

    Gothenburg, Sweden

  • Department of Oncology, Linköping University Hospital

    Linköping, Sweden

  • Department of Medicine, The Jubileum Institute, Lund University

    Lund, Sweden

  • Dept of Surgery, Karolinska Hospital, Stockholm

    Stockholm, Sweden

  • Uppsala University Hospital - Dept of Medical Sciences

    Uppsala, Sweden

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.